Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Peritoneal Ultrafiltration for Chronic Congestive Heart Failure: Rationale, Evidence and Future

      a , b

      Cardiology

      S. Karger AG

      Congestive heart failure, Peritoneal dialysis, Ultrafiltration

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Peritoneal dialysis (PD) was the first dialytic therapy used to achieve euvolemia in individuals with refractory congestive heart failure. PD remains a viable therapy for the short-term management of refractory congestive heart failure, and fluid removal rates comparable to those obtained with the continuous extracorporeal therapies can be achieved. However, with advances in extracorporeal therapies, the role of PD in these situations is limited to those individuals in whom vascular access cannot be obtained or if extracorporeal therapies are not available. On the other hand, PD is the ultrafiltration therapy of choice for the long-term ambulatory management of individuals with refractory congestive heart failure, either as a palliative therapy or as a bridge to definitive surgery or transplantation. A reduction in hospitalization rates and an improvement in functional capacity can be expected under such circumstances; however, survival is unlikely to be affected.

          Related collections

          Most cited references 4

          • Record: found
          • Abstract: not found
          • Article: not found

          Peritoneal dialysis for refractory congestive heart failure.

           A Brest,  O Ramirez,  C Heider (1967)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis.

            This article reports the treatment with continuous ambulatory peritoneal dialysis of a patient with intractable congestive heart failure secondary to an ischemic cardiomyopathy. Although the use of peritoneal dialysis to treat refractory heart failure is not new, the advent of an effective continuous peritoneal dialysis system has allowed its use over prolonged periods of time. The two-year treatment interval described herein represents the longest reported application of this technique, to the best of our knowledge.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases

               J. RUBIN,  J Rubin,  R Ball (1986)
                Bookmark

                Author and article information

                Journal
                CRD
                Cardiology
                10.1159/issn.0008-6312
                Cardiology
                S. Karger AG
                978-3-8055-7380-1
                978-3-318-00820-3
                0008-6312
                1421-9751
                2001
                2001
                18 January 2002
                : 96
                : 3-4
                : 177-182
                Affiliations
                aDirector, Peritoneal Dialysis Program, Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, Calif., bDirector, Division of Nephrology, University of Missouri-Columbia, Columbia, Mo., USA
                Article
                47401 Cardiology 2001;96:177–182
                10.1159/000047401
                11805384
                © 2002 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                Page count
                Figures: 5, Tables: 2, References: 45, Pages: 6
                Categories
                Paper

                Comments

                Comment on this article